Georgios Ioannidis

An international study to revise the EORTC questionnaire for assessing quality of life in lung cancer patients

Michael Koller, M.J. Hjermstad, Krzysztof A. Tomaszewski et al. · Annals of Oncology · 2017 · 77 citations · Full text

Pharmacy, Oncology, Health Assessment +15

ERCC1 and BRAC1 mRNA Expression Levels in the Primary Tumor Could Predict the Effectiveness of the Second-Line Cisplatin-Based Chemotherapy in Pretreated Patients with Metastatic Non-small Cell Lung Cancer

Chara Papadaki, Maria Sfakianaki, Georgios Ioannidis et al. · Journal of Thoracic Oncology · 2012 · 74 citations

Medicine, Oncology, Pharmacology +11

PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer

Chara Papadaki, Maria Sfakianaki, Eleni Lagoudaki et al. · British Journal of Cancer · 2014 · 60 citations · Full text

Medicine, Oncology, Pharmacology +16

Quality of Life in Patients With Hypoparathyroidism After Treatment for Thyroid Cancer

Matthias Büttner, Laura D. Locati, Monica Pinto et al. · The Journal of Clinical Endocrinology & Metabolism · 2020 · 54 citations · Full text

Medicine, Oncology, Cancer Survivorship Care +13

Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study

Michael Koller, Omar Shamieh, Marianne Jensen Hjermstad et al. · The Lancet Oncology · 2020 · 53 citations · Full text

Pharmacy, Oncology, Outcomes Research +16